Mayo Clinic Discovery Leads to FDA Approval for Stem Cell …

Posted: Published on June 14th, 2014

This post was added by Dr. Richardson

Dennis Douda (@ddouda) published a blog post January 17th, 2014

Mayo Clinic Discovery Leads to FDA Approval for Stem Cell Trial for Heart Failure Patients

U.S. FDA Approves Phase III Cardiopoietic Stem Cell Trial for Heart Failure Patients Based on a Mayo Discovery

Cardio3 BioSciences, an international Mayo Clinic collaborator, has received FDA approval for a phase III pivotal clinical trial of its stem cell therapy.The trial will test the Mayo Clinic discovery of cardiopoietic (cardiogenically-instructed) stem cells designed to improve heart health in people suffering from heart failure.The multisite U.S. trial, called CHART-2, will aim to recruit 240 patients with chronic advanced symptomatic heart failure. Cardio3 BioSciences is a bioscience company in Mont-Saint-Guibert, Belgium.

"Regenerative medicine is poised to transformthe way we treat patients," says Andre Terzic, M.D., Ph.D., director of the Mayo Clinic Center for Regenerative Medicine. Watch the video below to see how stem cells are being used to treat people with heart failure.

Journalists: Video b-roll of today's news conference, plussound bites with Dr. Terzic and Christian Homsy, M.D., CEO of Cardio3 BioSciences, areavailable in the downloads. The video pkg. is also available in the downloads in MOV format.

Cardio3 Biosciencescardiopoetic Dr. Andre Terzic Dr Terzic heart Heart Diseaseregenerative medicine stem cells

Go here to read the rest:
Mayo Clinic Discovery Leads to FDA Approval for Stem Cell ...

Related Posts
This entry was posted in FDA Stem Cell Trials. Bookmark the permalink.

Comments are closed.